Reversal in the trends of atherosclerosis-associated cerebrovascular disease mortality in the United States, 1999-2020

Curr Probl Cardiol. 2024 Nov 23:102935. doi: 10.1016/j.cpcardiol.2024.102935. Online ahead of print.

Abstract

Background: Cerebrovascular disease (CEVD) accounts for the second leading cause of death worldwide. Despite recent advancements in treatment strategies, the prevalence and cost associated with CEVD are rising. Atherosclerosis significantly contributes to CEVD risk by restricting cerebral blood flow, leading to ischemic stroke. This study aims to analyze trends in atherosclerosis-associated CEVD mortality in the United States from 1999 to 2020 to inform targeted prevention and management strategies.

Methods: We examined death certificates sourced from the CDC WONDER database, from 1999 to 2020 to identify atherosclerosis-associated CEVD mortality. Age-adjusted mortality rates (AAMRs) per 100,000 persons and annual percent changes were reported.

Results: A total of 325,401 deaths occurred from CEVD among adults with atherosclerosis from 1999 to 2020 in the US. The overall AAMR initially inclined from 10.9 in 1999 to 12.6 in 2001, followed by a decrease to 4.2 in 2016, and then a rise till 2020 was observed. Males had consistently higher AAMRs than females throughout the study period (Men = 11.9 vs Women = 10.1). When stratified by race, AAMRs were highest among non-Hispanic (NH) Whites (6.9), followed by NH American Indian/Alaska Native (10.9), NH Blacks/African Americans (6.6), Hispanics (4.9), and lastly by Asian/Pacific Islanders (4.2). The Western region had the highest mortality (AAMR: 7.7).

Conclusion: The CEVD mortality rates of adults with atherosclerosis- are increasing in the adult U.S.

Population: This underscores the need for increased screening, aggressive management, and subsequent surveillance of patients at risk.

Keywords: Atherosclerosis; CDC; cerebrovascular disease; mortality.

Publication types

  • Review